James Edgemond | Chief Financial Officer |
Martine Rothblatt | Chairman and CEO |
Michael Benkowitz | President and COO |
Jim White | MD, PhD from University Rochester Medical Center |
Hartaj Singh | Oppenheimer & Company |
Liana Moussatos | Wedbush Securities |
Martin Ulster | Credit Suisse |
Liana Moussatos | Wedbush Securities |
Good morning and welcome to United Therapeutics Corporation Fourth Quarter and Full Year 2018 Earnings Call. My name is Nicole, and I'll be your conference operator today. [Operator Instructions] I will now to turn the conference over to James Edgemond, Chief Financial Officer of United Therapeutics.
Thank you. Good morning.